TY - JOUR
T1 - Costs associated with influenza-related hospitalization in the elderly
AU - the Working Group of the Project PI12/02079
AU - Torner, Núria
AU - Navas, Encarna
AU - Soldevila, Núria
AU - Toledo, Diana
AU - Navarro, Gemma
AU - Morillo, Aurea
AU - Pérez, Maria José
AU - Domínguez, Angela
AU - Mayoral, J. M.
AU - Díaz-Borrego, J.
AU - Morillo, A.
AU - Pérez-Lozano, M. J.
AU - Gutiérrez, J.
AU - Pérez-Ruiz, M.
AU - Fernández-Sierra, M. A.
AU - Tamames, S.
AU - Rojo-Rello, S.
AU - Ortiz de Lejarazu, R.
AU - Fernández-Natal, M. I.
AU - Fernández-Villa, T.
AU - Pueyo, A.
AU - Martin, Vicente
AU - Vilella, A.
AU - Campins, M.
AU - Antón, A.
AU - Navarro, G.
AU - Riera, M.
AU - Espejo, E.
AU - Mas, M. D.
AU - Pérez, R.
AU - Cayla, J. A.
AU - Rius, C.
AU - Godoy, P.
AU - Torner, N.
AU - Izquierdo, C.
AU - Torra, R.
AU - Force, L.
AU - Domínguez, A.
AU - Soldevila, N.
AU - Crespo, I.
AU - Toledo, D.
AU - Astray, J.
AU - Domínguez-Berjon, M. F.
AU - Gutiérrez, M. A.
AU - Jiménez, S.
AU - Gil, E.
AU - Martín, F.
AU - Génova-Maleras, R.
AU - Prados, M. C.
AU - Enzzine de Blas, F.
N1 - Publisher Copyright:
© 2017 Taylor & Francis.
PY - 2017
Y1 - 2017
N2 - Seasonal influenza epidemics remain a considerable burden in adults, especially in those at higher risk of complications. The aim of this study was to determine the costs associated with influenza-related hospitalization in patients aged ≥65 y admitted to 20 hospitals from 7 Spanish regions during the 2013–14 and 2014–15 influenza seasons. Bivariate analysis was used to compare costs in vaccinated and unvaccinated cases. Costs were calculated according to the Spanish National Health System diagnosis-related group tables for influenza and other respiratory system conditions (GRD 89 and GRD 101). A total of 728 confirmed influenza cases were recorded: 52.9% were male, 46.7% were aged 75–84 years, and 49.3% received influenza vaccine ≥15 d prior to hospital admission. Influenza-related mean hospitalization costs (MHC) were € 1,184,808 in unvaccinated and € 1,152,333 in vaccinated cases (2.75% lower). Influenza vaccination showed significant protection against ICU admission (OR 0.35, 95%CI 0.21–0.59; p < 0001); mechanical ventilation (OR 0.56, 95%CI 0.39–0.80; p = 0.002); secondary bacterial pneumonia (OR 0.61, 95%CI 0.39–0.98; p = 0.04) and a higher degree of dependence (OR 0.74, 95%CI 0.55–0.99; p = 0.04). No association was observed for the Charlson comorbidity index or the mean hospital stay. Although influenza vaccination of the elderly may not achieve significant savings in mean hospitalization costs, it may lessen the degree of severity and avoid complications.
AB - Seasonal influenza epidemics remain a considerable burden in adults, especially in those at higher risk of complications. The aim of this study was to determine the costs associated with influenza-related hospitalization in patients aged ≥65 y admitted to 20 hospitals from 7 Spanish regions during the 2013–14 and 2014–15 influenza seasons. Bivariate analysis was used to compare costs in vaccinated and unvaccinated cases. Costs were calculated according to the Spanish National Health System diagnosis-related group tables for influenza and other respiratory system conditions (GRD 89 and GRD 101). A total of 728 confirmed influenza cases were recorded: 52.9% were male, 46.7% were aged 75–84 years, and 49.3% received influenza vaccine ≥15 d prior to hospital admission. Influenza-related mean hospitalization costs (MHC) were € 1,184,808 in unvaccinated and € 1,152,333 in vaccinated cases (2.75% lower). Influenza vaccination showed significant protection against ICU admission (OR 0.35, 95%CI 0.21–0.59; p < 0001); mechanical ventilation (OR 0.56, 95%CI 0.39–0.80; p = 0.002); secondary bacterial pneumonia (OR 0.61, 95%CI 0.39–0.98; p = 0.04) and a higher degree of dependence (OR 0.74, 95%CI 0.55–0.99; p = 0.04). No association was observed for the Charlson comorbidity index or the mean hospital stay. Although influenza vaccination of the elderly may not achieve significant savings in mean hospitalization costs, it may lessen the degree of severity and avoid complications.
KW - Influenza
KW - cost
KW - elderly
KW - hospitalization
KW - immunization
UR - http://www.scopus.com/inward/record.url?scp=85010651416&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010651416&partnerID=8YFLogxK
U2 - 10.1080/21645515.2017.1264829
DO - 10.1080/21645515.2017.1264829
M3 - Article
C2 - 27925855
AN - SCOPUS:85010651416
SN - 2164-5515
VL - 13
SP - 412
EP - 416
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
IS - 2
ER -